Augmentation of in-vitro clot dissolution by low frequency high-intensity ultrasound combined with antiplatelet and antithrombotic drugs

Journal of Thrombosis and Thrombolysis

Volumn 11, Issue 3, 2001, Pages 223-228

  Altar, S ^a   Luo, H ^a   Birnbaum, Y ^a   Nagai, T ^a   Siegel, R J ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Anti platelet; Heparin; Thrombolysis; Tirofiban; Ultrasonic

Indexed keywords

ALTEPLASE; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; FS 069; HEPARIN; TIROFIBAN; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD ANALYSIS; BLOOD CLOT LYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; FREQUENCY MODULATION; HEART MUSCLE ISCHEMIA; HUMAN; IN VITRO STUDY; INCUBATION TIME; PRIORITY JOURNAL; RANDOMIZATION; STATISTICAL ANALYSIS; ULTRASOUND THERAPY; ULTRASOUND TRANSDUCER; WEIGHT REDUCTION;

BLOOD COAGULATION; COMBINED MODALITY THERAPY; DRUG COMBINATIONS; FIBRINOLYTIC AGENTS; HUMANS; PLATELET AGGREGATION INHIBITORS; ULTRASONIC THERAPY; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0035172116     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011912920777     Document Type: Article

References (33)

1. Platelet GP IIb-IIIa blockers
2. Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes
3. New antiplatelet agents for acute coronary syndromes
4. Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularization
5. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty
6. Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty
7. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina
8. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
9. Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy men
10. Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383
11. MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man
12. Enhancement of thrombolysis by external ultrasound
13. Intravascular therapeutic ultrasound thrombolysis in acute myocardial infarctions
14. Ultrasound enhancement of thrombolysis and reperfusion in vitro
15. Effect of ultrasound on tissue-type plasminogen activator-induced thrombolysis
16. Analysis of coronary ultrasound thrombolysis endpoints in acute myocardial infarction (ACUTE trial). Results of the feasibility phase
17. Catheter-delivered ultrasound potentiates in vitro thrombolysis
18. Ultrasound-assisted thrombolysis
19. Thrombolysis by ultrasound
20. Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis
21. Does external ultrasound accelerate thrombolysis? Results from a rabbit model
22. Characterization of ultrasound-potentiated fibrinolysis in vitro
23. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots
24. Flow through clots determines the rate and pattern of fibrinolysis
25. Dependence of blood clot lysis on the mode of transport of urokinase into the clot - A magnetic resonance imaging study in vitro
26. Ultrasound increases flow through fibrin gels
27. Acceleration of recombinant tissue-type plasminogen activator-induced thrombolysis and prevention of reocclusion by the combination of heparin and the Arg-Gly-Asp-containing peptide bitistatin in a canine model of coronary thrombosis
28. Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation
29. Enhancement of fibrinolysis with 40-kHz ultrasound
30. Enhancement of thrombolysis in vivo without skin and soft tissue damage by transcutaneous ultrasound
31. Transcutaneous ultrasound augments lysis of arterial thrombi in vivo
32. Dissolution of thrombotic arterial occlusion by high intensity, low frequency ultrasound and dodecafluoropentane emulsion: An in vitro and in vivo study
33. Noninvasive in vivo clot dissolution without a thrombolytic drug: Recanalization of thrombosed iliofemoral arteries by transcutaneous ultrasound combined with intravenous infusion of microbubbles